Aptimmune Biologics
Latest round
- Series A
Last raised
- Jul 2015
Total raised
- $2.8M
Investors
- 2
About Aptimmune Biologics
Aptimmune Biologics specializes in creating innovative vaccines combating swine pathogens.Aptimmune Biologics develops mucosal vaccines aimed at swine diseases, particularly focusing on Porcine Reproductive and Respiratory Syndrome Virus (PRRSV). Their products utilize cutting-edge vaccination technology to improve livestock health, making them essential for veterinary professionals and swine producers across North America, Europe, and select regions in Asia.Aptimmune Biologics generates revenue through direct sales of its vaccines, targeting veterinary professionals and swine producers for herd health management. The company engages in B2B transactions, supplying large-scale veterinary distributors and agricultural firms with bulk vaccines. Additional revenue avenues may include subscription services for ongoing support regarding vaccine efficacy.75 mn to enhance product development and market reach. Upcoming new vaccines are in the pipeline, with plans for expansion into European and Asian markets by 2025.
Who invested in Aptimmune Biologics
2 investors across 1 round
See all investors in Aptimmune Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 9, 2015
Amount
$2.8M
Investors
Questions about Aptimmune Biologics
Who invested in Aptimmune Biologics?
Aptimmune Biologics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aptimmune Biologics raised?
Aptimmune Biologics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Aptimmune Biologics last raise money?
Aptimmune Biologics's most recent round on record is a Series A, in Jul 2015.
What does Aptimmune Biologics do?
Aptimmune Biologics specializes in creating innovative vaccines combating swine pathogens.
Where is Aptimmune Biologics headquartered?
Aptimmune Biologics is headquartered in Champaign, US.
Which VCs invest in companies like Aptimmune Biologics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aptimmune Biologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Aptimmune Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.